lunes, 26 de agosto de 2019

The ALLERGY in ICD-11

Dear Friends, dear Colleagues,
As you may know, over the last 7 years we have been moving efforts for a better representation of allergic and hypersensitivity conditions in the World Health Organization's international classifications. The actions of the ALLERGY in ICD-11 initiative have been acknowledged by the Joint Allergy Academies (WAO, EAACI, AAAAI, ACAAI, APAAACI, SLAAI) and the WHO ICD governance, which resulted in the construction of the pioneer section addressed to these conditions in the International Classification of Diseases (ICD)-11. Recently, the ICD-11 has been fully endorsed by the members of states and we are now working in the implementation process.
With the aim of actively support the global implementation of the ICD-11 taking the allergic and hypersensitivity conditions as a model, we thank you very much for replying this online survey: https://docs.google.com/forms/d/e/1FAIpQLSdGS-fIN7Oy_74OKkIcu6_Oh0hZ9KzeMwSqN9PvM5XDy-AewA/viewform. We also kindly ask you for your support to cascade-down and to share it among your networks.
We intend to receive responses up to 20th September.
Thank you very much!
With our best wishes,
Luciana & Pascal
Luciana Kase Tanno, MD, PhD
Allergy and Clinical Immunology 
Rua Prof Arthur Ramos, 183, cj 21 
01454-011 São Paulo-SP Brazil 
Tel: 55-11-3815-4866 
 e-mail: luciana.tanno@gmail.com

Division of Allergy, Département de Pneumologie et Addictologie 
Hôpital Arnaud de Villeneuve - University Hospital of Montpellier
34295 Montpellier cedex 05 - FRANCE
Tel: +33 467336107 - Fax: +33 467634581
and Sorbonne Université INSERM, IPLESP, Equipe EPAR, 75013, Paris, France

Board member of the WHO Medical and Scientific Advisory Committee
Head of the WHO Collaborating Centre on Classification Scientific Support  

 

No hay comentarios:

Publicar un comentario

Nota: solo los miembros de este blog pueden publicar comentarios.

Desarrollan AsmaVida, una plataforma web para monitorizar el asma

Semergen ha anunciado el lanzamiento de esta plataforma, que ofrecerá a los pacientes llevar un seguimiento personalizado de su enfermedad. ...